Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lipids and risk assessment.

R Linde1, B Linde

  • 1Department of Endocrinology, Palo Alto Medical Foundation, 795 El Camino Real, Palo Alto, California 94301, USA.

Cardiology in Review
|November 7, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bronchial hyper-responsiveness: a technical update.

Occupational medicine (Oxford, England)·2018
Same author

Acousto-Optics 2017: introduction to the feature issue.

Applied optics·2018
Same author

An open, prospective trial investigating the pharmacokinetics and safety, and the tolerability of escalating infusion rates of a 10% human normal immunoglobulin for intravenous infusion (IVIg), BT090, in patients with primary immunodeficiency disease.

Vox sanguinis·2015
Same author

Pregnancy complications in HIV-positive women: 11-year data from the Frankfurt HIV Cohort.

HIV medicine·2014
Same author

The influence of stevia glycosides on the growth of Lactobacillus reuteri strains.

Letters in applied microbiology·2013
Same author

The German national registry for primary immunodeficiencies (PID).

Clinical and experimental immunology·2013
Same journal

Cardiotoxicity of Antibody-Drug Conjugates in HER2-Positive Cancer: Beyond Left Ventricular Ejection Fraction Decline.

Cardiology in review·2026
Same journal

Celiac Disease and Cardiovascular Disease: Epidemiology, Mechanisms, and Clinical Challenges.

Cardiology in review·2026
Same journal

Valve-Specific Comparative Effectiveness of Direct Oral Anticoagulants Versus Vitamin K Antagonists After Surgical Valve Procedures in Atrial Fibrillation: A Systematic Review and Meta-Analysis.

Cardiology in review·2026
Same journal

Growing Heart Valves in Congenital Cardiac Surgery: Mechanisms and Considerations for Tissue-Engineered Heart Valves, Noncryopreserved Homografts, and Partial Heart Transplantation.

Cardiology in review·2026
Same journal

Implementation Gaps and Limitations of Statin Therapy in Young Adults: Bridging Guideline Recommendations and Real-World Practice.

Cardiology in review·2026
Same journal

Cardiovascular Manifestations of Epilepsy.

Cardiology in review·2026
See all related articles

Standard lipid panels may hide atherosclerosis risks. Advanced tests like apolipoprotein B and lipoprotein (a) offer clearer cardiovascular risk assessment, especially with family history.

Area of Science:

  • Cardiovascular Medicine
  • Clinical Laboratory Science
  • Atherosclerosis Research

Background:

  • Standard lipid panels can inaccurately represent lipoprotein abnormalities.
  • Atherosclerosis risk assessment is crucial, particularly for individuals with a family history of premature coronary heart disease of uncertain cause.
  • Advanced laboratory analysis can provide a more precise understanding of cardiovascular risk.

Observation:

  • The review details seven male cardiologists who initially misinterpreted their cardiovascular risk based on conventional lipid testing.
  • This highlights a potential gap in relying solely on standard lipid panels for risk stratification.
  • The cases underscore the importance of considering advanced testing when clinical suspicion of risk is high.

Findings:

Related Experiment Videos

  • Detailed laboratory analysis, including apolipoprotein B, lipoprotein (a), and lipoprotein subfractions, can significantly clarify cardiovascular risk.
  • In selected cases, homocysteine measurements also aid in risk assessment.
  • Six of the seven cardiologists reviewed had a greater cardiovascular risk than initially recognized through standard tests.

    • Implications:

    • Clinicians should consider advanced lipid testing for patients with unclear cardiovascular risk or a family history of premature coronary heart disease.
    • More comprehensive laboratory analysis can lead to more accurate risk stratification and appropriate patient management.
    • This approach parallels using advanced imaging when standard methods are insufficient for diagnosis.